HLA-A*2601 & B2M Produktliste
You Have Viewed 0 Of 0 Results
Klinische Arzneimittelinformation
| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Latozinemab | AL-001; GSK-4527223 | Phase 3 Clinical | Alector Inc, Glaxosmithkline Plc | Bipolar Disorder; Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Neurodegenerative Diseases | Details |
| VES-001 | VES-001; VES001 | Phase 1 Clinical | Vesper Bio APS | Dementia; Frontotemporal Dementia | Details |